Skip to content

Air T AIRT Short-term restricted investments

Short-term restricted investments at other companies

UroGen Pharma logo
UroGen PharmaURGN
$177K+0.6%
Intercontinental Exchange logo
Intercontinental ExchangeICE
$884M+43.3%
VAL
Value LineVALU
$305K0.0%
UFP Industries, Inc. logo
UFP Industries, Inc.UFPI
$51.3M+22.0%
Ingevity logo
IngevityNGVT
$24.7M
DocGo logo
DocGoDCGO
$13.12M

Other financials

Income statement

See full
Revenue$120.9M+82.4%
Operating income-$13.8M
Net income$77.7M+1,206%
EPS (diluted)$28.75+1,227%

Balance sheet

See full
Cash & equivalents$20.3M+201%
Total debt$15.6M-87.5%
Total equity$79.8M+2,582%
Total assets$409.1M+135%

Cash flow

See full
Operating cash flow-$44.0K-101%
CapEx$15.3M+10,139%
Free cash flow-$15.3M-485%

Valuation

See full
Market cap$71.46M+17.6%
Enterprise value$66.72M-67.5%
P/E0.9×
P/S0.2×0.0×

Profitability

See full
Operating margin-3.5%
Net margin23.8%+22.1pp
FCF margin-12.7%-20.4pp

Returns & leverage

See full
Return on equity-157.8%-201pp
Debt / equity0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Air T in its filing.

Tagged under the XBRL concept us-gaap:RestrictedInvestmentsCurrent.

The official record: Air T’s 10-K, filed June 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Air T's short-term restricted investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Air T's short-term restricted investments?
Air T (AIRT) reported short-term restricted investments of $0 in Q1 2026.
How has Air T's short-term restricted investments changed year-over-year?
Air T's short-term restricted investments decreased by 100.0% year-over-year, from $683K to $0.
What is the long-term trend for Air T's short-term restricted investments?
Over 4 years (2022 to 2026), Air T's short-term restricted investments has grown at a -100.0% compound annual growth rate (CAGR), from $1.69M to $0.